E. P. Mauser‐Bunschoten

1.9k citations

34 papers · 1.4k indexed · h-index 19

Hematology top 0.5%
- Hemophilia Treatment and Research 18
- Platelet Disorders and Treatments 13
- Blood Coagulation and Thrombosis Mechanisms 7
- Chronic Myeloid Leukemia Treatments 4
Hepatology top 2%
- Hepatitis C virus research 9
Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
Epidemiology top 10%
- Hepatitis B Virus Studies 5
- Liver Disease Diagnosis and Treatment 3
Internal Medicine

Co-authors: G. Roosendaal H K Nieuwenhuis Johanna G. van der Bom H. Marijke van den Berg Arja de Goede-Bolder Kathelijn Fischer P.N. Lelie Marjolein Peters
Cited by: Hematology Hepatology Genetics
Partner nations: Netherlands United States Germany

In The Last Decade

E. P. Mauser‐Bunschoten

34 papers receiving 1.4k citations

Peers

Countries citing papers authored by E. P. Mauser‐Bunschoten

Since Specialization

Citations

This map shows the geographic impact of E. P. Mauser‐Bunschoten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. P. Mauser‐Bunschoten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. P. Mauser‐Bunschoten more than expected).

Fields of papers citing papers by E. P. Mauser‐Bunschoten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. P. Mauser‐Bunschoten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. P. Mauser‐Bunschoten. The network helps show where E. P. Mauser‐Bunschoten may publish in the future.

Co-authorship network

The 25 scholars most cited alongside E. P. Mauser‐Bunschoten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E. P. Mauser‐Bunschoten Line = papers co-authored together E. P. Mauser‐Bunschoten links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Maternal and neonatal bleeding complications in relation to peripartum management in hemophilia carriers: A systematic review Marieke C. Punt,M.L. Waning,E. P. Mauser‐Bunschoten,Marieke J.H.A. Kruip,Jeroen Eikenboom,Laurens Nieuwenhuizen,Anja BU Mäkelburg,M.H.E. Driessens,Johannes J. Duvekot,Marjolein Peters,Jaap M. Middeldorp,Kitty W.M. Bloemenkamp,Roger E. G. Schutgens,A. Titia Lely,Karin P. M. van Galen	2021	14
2	Anticoagulation therapy in haemophilia A. Tuinenburg,Kathelijn Fischer,E. P. Mauser‐Bunschoten,(unknown)	2013	13
3	Health‐related quality of life among adult patients with moderate and severe von Willebrand disease Eva M. de Wee,E. P. Mauser‐Bunschoten,Johanna G. van der Bom,M. Degenaar-Dujardin,Jeroen Eikenboom,Karin Fijnvandraat,Arja de Goede-Bolder,Britta A. P. Laros‐van Gorkom,Karina Meijer,Hein Raat,Frank W.G. Leebeek	2010	81
4	Impact of von Willebrand disease on health‐related quality of life in a pediatric population Eva M. de Wee,Karin Fijnvandraat,Arja de Goede-Bolder,E. P. Mauser‐Bunschoten,Jeroen Eikenboom,Paul Brons,Frans J. Smiers,R. Y. J. Tamminga,Rianne Oostenbrink,Hein Raat,Johanna G. van der Bom,Frank W.G. Leebeek	2010	32
5	Cardiovascular disease in patients with hemophilia A. Tuinenburg,E. P. Mauser‐Bunschoten,Marianne C. Verhaar,Douwe H. Biesma,Roger E. G. Schutgens	2009	95
6	Antiviral therapy for chronic hepatitis C in patients with inherited bleeding disorders: an international, multicenter cohort study Dirk Posthouwer,T. T. Yee,Michael Makris,Kathelijn Fischer,Anja Griffioen,Joost J. van Veen,E. P. Mauser‐Bunschoten	2007	31
7	Mortality and causes of death in patients with hemophilia, 1992–2001: a prospective cohort study Iris Plug,Johanna G. van der Bom,Marjolein Peters,E. P. Mauser‐Bunschoten,Arja de Goede-Bolder,L. Heijnen,Cees Smit,J. Willemse,F.R. Rosendaal	2006	224
8	[Oral surgery in hemophilia patients]. H. Mokhtari,G. Roosendaal,R. Koole,E. P. Mauser‐Bunschoten,H M van den Berg	2003	3
9	Efficacy of recombinant factor VIIa administered by continuous infusion to haemophilia patients with inhibitors E. P. Mauser‐Bunschoten,M.M.W. Koopman,Arja de Goede-Bolder,Frank W.G. Leebeek,J. van der Meer,Gijs Kooij,P.W.G. van der Linden,(unknown)	2002	25
10	Improvement of patient education and information: development of a patient's information dossier E. P. Mauser‐Bunschoten,M. J. Hamers,Dewald Roode,G. Terlingen‐Van Baaren,P. de Kleijn,R. Bos,H. Marijke van den Berg	2001	3
11	Improvement of patient education and information: development of a patient’s information dossier E. P. Mauser‐Bunschoten,M. J. Hamers,Dewald Roode,G. Terlingen‐Van Baaren,P. de Kleijn,R. Bos,H. Marijke van den Berg	2001	1
12	Continuous infusion of recombinant factor VIIa in patients with haemophilia and inhibitors Experience in the Netherlands and Belgium. E. P. Mauser‐Bunschoten	1998	40
13	High prevalence of parvovirus B19 IgG antibodies among Dutch hemophilia patients. E. P. Mauser‐Bunschoten,Hans L. Zaaijer,A.A.J. van Drimmelen,S. de Vries,G. Roosendaal,H. Marijke van den Berg,P.N. Lelie	1998	24
14	Effect and side‐effects of alpha interferon treatment in haemophilia patients with chronic hepatitis C E. P. Mauser‐Bunschoten,Dorine Bresters,H. W. Reesink,G. Roosendaal,R Chamuleau,Erik de Haan,Plm Jansen,H. Marijke van den Berg	1995	8
15	Low-dose immune tolerance induction in hemophilia A patients with inhibitors E. P. Mauser‐Bunschoten,H K Nieuwenhuis,G Roosendaal,HM van den Berg	1995	4
16	Immunetolerance as treatment of alloantibodies to factor VIII in hemophilia. The International Registry of Immunetolerance Protocols. Giuliano Mariani,E. Scheibel,T Nogao,Kasper Ck,Ewing Np,E. P. Mauser‐Bunschoten,Alessandro Ghirardini,Rino Bellocco,Brackman Hh	1994	38
17	Clinical Course of Factor VIII Inhibitors Developed after Exposure to a Pasteurised Dutch Concentrate Compared to Classic Inhibitors in Hemophilia A E. P. Mauser‐Bunschoten,Frits R. Rosendaal,H K Nieuwenhuis,G. Roosendaal,Ernest Briëf,H. Marijke van den Berg	1994	42
18	Comparison of quantitative cDNA‐PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trial Dorine Bresters,H. T. M. Cuypers,H. W. Reesink,E. P. Mauser‐Bunschoten,H. Marijke van den Berg,W. P. Schaasberg,Judith C. Wilber,M S Urdea,Paul Neuwald,P.N. Lelie	1994	29
19	Sexual transmission of hepatitis C virus Dorine Bresters,H. W. Reesink,C.L. van der Poel,H.W. Reesink,H. T. M. Cuypers,P.N. Lelie,E. P. Mauser‐Bunschoten,G. Roosendaal,H. Marijke van den Berg,Robert A.F.M. Chamuleau,P. L. M. Jansen,Christine J. Weegink	1993	166
20	Prevalence of Anti‐HCV Antibodies Confirmed by Recombinant Immunoblot in Different Population Subsets in The Netherlands C.L. van der Poel,H. W. Reesink,E. P. Mauser‐Bunschoten,R Kaufmann,A Leentvaar-Kuypers,R Chamuleau,W. P. Schaasberg,Ed Bakker,P.J. Exel‐Oehlers,I. Theobalds,J.J. P. Van Boven,Andrew Cameron,P.N. Lelie	1991	33

About E. P. Mauser‐Bunschoten

E. P. Mauser‐Bunschoten is a scholar working on Hematology, Hepatology and Genetics, having authored 34 papers that have together received 1.4k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (18 papers), Platelet Disorders and Treatments (13 papers), Hepatitis C virus research (9 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers), Hepatitis B Virus Studies (5 papers), Chronic Myeloid Leukemia Treatments (4 papers), Liver Disease Diagnosis and Treatment (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). The work is most often cited by research in Hematology (1.1k citations), Hepatology (316 citations) and Genetics (341 citations). E. P. Mauser‐Bunschoten has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include G. Roosendaal, H K Nieuwenhuis, Johanna G. van der Bom, H. Marijke van den Berg, Arja de Goede-Bolder, Kathelijn Fischer, P.N. Lelie, Marjolein Peters, Cees Smit and H. W. Reesink.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact